Classification Criteria for Spondyloarthritis/HLA-B27-Associated Anterior Uveitis.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
08 2021
Historique:
received: 11 07 2020
revised: 29 01 2021
accepted: 31 03 2021
pubmed: 13 4 2021
medline: 16 11 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

The purpose of this study was to determine classification criteria for spondyloarthritis/HLA-B27-associated anterior uveitis DESIGN: Machine learning of cases with spondyloarthritis/HLA-B27-associated anterior uveitis and 8 other anterior uveitides. Cases of anterior uveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used in the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the anterior uveitides. The resulting criteria were evaluated in the validation set. A total of 1,083 cases of anterior uveitides, including 184 cases of spondyloarthritis/HLA-B27-associated anterior uveitis, were evaluated by machine learning. The overall accuracy for anterior uveitides was 97.5% in the training set and 96.7% in the validation set (95% CI: 92.4-98.6). Key criteria for spondyloarthritis/HLA-B27-associated anterior uveitis included 1) acute or recurrent acute unilateral or unilateral alternating anterior uveitis with either spondyloarthritis or a positive test result for HLA-B27; or 2) chronic anterior uveitis with a history of the classic course and either spondyloarthritis or HLA-B27; or 3) anterior uveitis with both spondyloarthritis and HLA-B27. The misclassification rates for spondyloarthritis/HLA-B27-associated anterior uveitis were 0% in the training set and 3.6% in the validation set. The criteria for spondyloarthritis/HLA-B27-associated anterior uveitis had a low misclassification rate and appeared to perform well enough for use in clinical and translational research.

Identifiants

pubmed: 33845004
pii: S0002-9394(21)00174-4
doi: 10.1016/j.ajo.2021.03.049
pmc: PMC8594762
mid: NIHMS1692715
pii:
doi:

Substances chimiques

HLA-B27 Antigen 0

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-125

Subventions

Organisme : NEI NIH HHS
ID : R01 EY026593
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Best Pract Res Clin Rheumatol. 2010 Oct;24(5):589-604
pubmed: 21035082
Ophthalmology. 2010 Feb;117(2):366-72
pubmed: 20006905
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
Ann Rheum Dis. 2011 Jan;70(1):25-31
pubmed: 21109520
Ann Rheum Dis. 2008 Jul;67(7):955-9
pubmed: 17962239
Arthritis Res Ther. 2018 Feb 7;20(1):22
pubmed: 29415753
Am J Ophthalmol. 2018 Feb;186:19-24
pubmed: 29122577
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Am J Ophthalmol. 1995 Sep;120(3):351-61
pubmed: 7661207
Ann Rheum Dis. 2009 Jun;68(6):770-6
pubmed: 19297345
JAMA Ophthalmol. 2013 Jun;131(6):787-9
pubmed: 23764704
Arthritis Rheum. 2006 Aug;54(8):2665-73
pubmed: 16871531
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
Methods Inf Med. 2013;52(3):259-65, S1-6
pubmed: 23392263
Am J Ophthalmol. 2013 Aug;156(2):228-36
pubmed: 23668682
J Rheumatol. 1989 Jun;16(6):792-6
pubmed: 2778762
Am J Ophthalmol. 1996 Jan;121(1):47-56
pubmed: 8554080
Am J Ophthalmol. 1991 Sep 15;112(3):317-21
pubmed: 1882942
Br J Rheumatol. 1985 Aug;24(3):242-9
pubmed: 3160423
Ophthalmology. 2004 Apr;111(4):802-9
pubmed: 15051216
Arthritis Care Res (Hoboken). 2015 Jul;67(7):891-7
pubmed: 25776731

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH